Zenith Epigenetics Announces Appointment to Board of Directors and Provides Clinical Update

3 years ago

CALGARY, Alberta, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announced the appointment of…

Medexus Schedules Third Quarter Fiscal 2022 Conference Call

3 years ago

TORONTO and CHICAGO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF)…

Spectral Medical Announces U.S. FDA Approval of DIMI Trial Protocol Amendment

3 years ago

Amendment expected to overcome key pandemic challenges and improve both site and patient enrollmentTORONTO, Jan. 31, 2022 (GLOBE NEWSWIRE) --…

Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services

3 years ago

Completed first phase of contract for $50 million; HHS options to procure up to $31 million of ANTHIM by the…

Olema Oncology Appoints Naseem Zojwalla, M.D., as Chief Medical Officer

3 years ago

• Dr. Zojwalla brings extensive and diverse experience in clinical development and regulatory strategy for novel oncology therapies • As part…

BrainsWay Announces Final Local Coverage Determination Issued by Regional Medicare Administrative Contractor Palmetto GBA Providing Coverage of Deep TMS™ for the Treatment of OCD

3 years ago

Palmetto GBA Covers Medicare Patients in Seven StatesBURLINGTON, Mass. and JERUSALEM, Jan. 31, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ…

Quipt Announces Revocation of Management Cease Trade Order

3 years ago

CINCINNATI, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based…

Humacyte Announces Clinical Case Series Demonstrating Potential of Human Acellular Vessel™ (HAV™) to Expand Opportunities for Limb Salvage in Multiple Complex Vascular Reconstruction Scenarios

3 years ago

– Outcomes of first eight compassionate use cases presented at 46th Annual Winter Meeting of the Vascular and Endovascular Surgery Society…

Biogen Announces Nancy Leaming and Brian Posner to Retire from Board of Directors

3 years ago

CAMBRIDGE, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that Nancy Leaming and Brian Posner…

InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App

3 years ago

InteliSwab test With less than one minute of “hands-on time,” the InteliSwab test is as simple as “Swab, Swirl, and…